Founders Financial Alliance’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$555K Buy
9,145
+1,347
+17% +$78.5K 0.1% 193
2025
Q4
$421K Sell
7,798
-1,654
-17% -$79.6K 0.08% 222
2025
Q3
$426K Buy
9,452
+1,407
+17% +$65.7K 0.08% 228
2025
Q2
$372K Sell
8,045
-241
-3% -$11.8K 0.08% 222
2025
Q1
$505K Sell
8,286
-95
-1% -$5.54K 0.12% 166
2024
Q4
$474K Sell
8,381
-36
-0.4% -$2.01K 0.13% 151
2024
Q3
$435K Buy
8,417
+27
+0.3% +$1.27K 0.12% 161
2024
Q2
$348K Buy
8,390
+1,287
+18% +$57.6K 0.1% 191
2024
Q1
$385K Buy
7,103
+275
+4% +$14K 0.12% 181
2023
Q4
$350K Buy
6,828
+106
+2% +$5.56K 0.14% 162
2023
Q3
$390K Sell
6,722
-783
-10% -$48K 0.17% 122
2023
Q2
$480K Buy
7,505
+577
+8% +$38.7K 0.19% 112
2023
Q1
$481K Sell
6,928
-439
-6% -$31K 0.24% 100
2022
Q4
$530K Buy
7,367
+320
+5% +$24.1K 0.24% 98
2022
Q3
$501K Buy
7,047
+849
+14% +$61.6K 0.26% 92
2022
Q2
$477K Sell
6,198
-990
-14% -$75.4K 0.24% 97
2022
Q1
$525K Sell
7,188
-570
-7% -$38.3K 0.23% 98
2021
Q4
$484K Buy
7,758
+574
+8% +$33.7K 0.19% 115
2021
Q3
$424K Buy
7,184
+110
+2% +$7.24K 0.2% 117
2021
Q2
$473K Buy
7,074
+215
+3% +$14K 0.22% 108
2021
Q1
$443K Buy
6,859
+1,564
+30% +$97.3K 0.22% 103
2020
Q4
$327K Buy
5,295
+801
+18% +$49.3K 0.18% 127
2020
Q3
$272K Buy
+4,494
New +$270K 0.16% 123

Other funds holding BMY

Founders Financial Alliance's BMY Position: Q1 2026 in Review

Founders Financial Alliance increased its Bristol-Myers Squibb (BMY) stake by 17% in Q1 2026, buying an estimated $78.5K and bringing the position to 9,145 shares worth $555K. The position accounts for 0.1% of the portfolio, ranked #193.

Founders Financial Alliance first reported a position in BMY in Q3 2020 and has held it in 23 quarters since. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Founders Financial Alliance held 9,145 shares of Bristol-Myers Squibb worth $555K as of Q1 2026.
  • Founders Financial Alliance bought 1,347 Bristol-Myers Squibb shares in Q1 2026, an estimated $78.5K.
  • Bristol-Myers Squibb made up 0.1% of Founders Financial Alliance's portfolio in Q1 2026, its #193 holding.
  • Founders Financial Alliance first reported a position in Bristol-Myers Squibb in Q3 2020 and has held it in 23 quarters since.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Founders Financial Alliance's 13F filing for Q1 2026, filed 11 May 2026.